tirzepatide is the same as zepbound FDA approval for (tirzepatide) injection, first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Zepbound® (Tirzepatide) | Mochi Health

Yes, with a clear dose-response relationship: 0.25 mg dose: 9-11% constipation rate 0.5 mg dose: 12-14% constipation rate 1.0 mg dose: 15-18% constipation rate 2.4 mg dose: 23-24% constipation rate The increase from 0.5 mg to 2.4 mg roughly doubles the constipation risk

Used to supplement diet and exercise, improve glycemic control in adults with type 2 diabetes, and significantly reduce the risk of major cardiovascular events in type 2 diabetes

Koozehchian MS, Daneshfar A, Fallah E, Agha-Alinejad H, Samadi M, Kaviani M, Kaveh B M, Jung YP, Sablouei MH, Moradi N, Earnest CP, Chandler TJ, Kreider RB. Effects of nine weeks L-Carnitine supplementation on exercise performance, anaerobic power, and exercise-induced oxidative stress in resistance-trained males. J Exerc Nutrition Biochem. 2018 Dec 31;22(4):7-19. doi: 10.20463/jenb.2018.0026. PMID: 30661327; PMCID: PMC6343764

What Do "Overweight" and "Obesity" Mean